For this is a new warófor technology and skill, for the human brain, for gene supremacy and for the ultimate knowledge. Like the blind librarian Borges in Umberto Eco's The Name of the Rose, the rich corporations guard the door to knowledge. As globalisation has bridged distances, sped up communication and erased borders, there has also emerged a digital divide between the rich and poor, black and white, men and women, the connected and the unconnected. Poor people and poor countries risk being marginalised in this proprietary regime controlling knowledge. Even though developing countries are home to an estimated 90 per cent of the world's store of biological resources. Today, more strategic alliances are being struck between pharma firms and the governments or indigenous groups in resource-rich countries. Or, in the absence of proper institutional framework for governance, shamelessly lifted, as illustrated by patents taken out in the West on basmati rice, turmeric plant, bitter gourd or neem leaves. Money talks louder than need in biotech researchó'cosmetic drugs and slow-ripening tomatoes come higher on the list than a vaccine against malaria or drought-resistant crops'.